RxDoctor Payments Data

Erin Robinson

Psychiatric/Mental Health · Nashville, TNNPI 1720364987

Payments from drug & device makers

$967in general payments, 2019–2025

Across 73 payments — averaging $13.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$329
  • Teva Pharmaceuticals USA, Inc.$217
  • Otsuka America Pharmaceutical, Inc.$215
  • Alkermes, Inc.$47
  • Hologic Sales And Service, LLC$46
  • Vanda Pharmaceuticals Inc.$29
  • plus $83 from 5 others

What the payments were for

  • Food & beverage$86189%
  • Education$10611%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$967 in reported general payments places this provider in the 55th percentile of 1,167 psychiatric/mental health providers in Tennessee.

See all psychiatric/mental health providers in Tennessee

Medicare billing

Part B allowed, 2024
$12,327
Medicare patients
39
Services billed
149

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine23$267,781
RexultiBrexpiprazole110$188,117
VraylarCariprazine Hcl22$30,580
TrintellixVortioxetine Hydrobromide34$22,537
Lisdexamfetamine Dimesylate42$10,916
VyvanseLisdexamfetamine Dimesylate20$7,784
Desvenlafaxine Succinate ErDesvenlafaxine Succinate109$6,961
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine55$5,465
Vilazodone Hcl37$4,898
DayvigoLemborexant14$4,595
Ramelteon25$3,243
Olanzapine51$2,399
Dextroamphetamine Sulfate21$2,114
Duloxetine Hcl81$2,092
Methylphenidate Hcl49$2,034

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$217$267,78123 claims
Otsuka America Pharmaceutical, Inc.Rexulti$215$188,117110 claims
AbbVieVraylar$329$30,58022 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 1,167 psychiatric/mental health providers in Tennessee.

Other psychiatric/mental health in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →